Tags: Glox Therapeutics\bacteriocin development programme\antimicrobial resistance\AMR\Boehringer Ingelheim Venture Fund \
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Mitsui O.S.K. Lines Offshore Engineer | MOL Gets ClassNK Blessing for Ammonia FSRU Design - 4 months ago | |
| 2 | MHI Group's Mitsubishi Shipbuilding Offshore Engineer | MOL Gets ClassNK Blessing for Ammonia FSRU Design - 4 months ago | |
| 3 | Devin Meenan RISMedia | ||
| 4 | Best Buy Ads Digiday | ||
| 5 | Elizabeth Cooney STAT News | ||
| 6 | Louis Columbus VentureBeat Husband. Dad. Loves teaching, travel. | The age of weaponized LLMs is here - 4 months ago | |
| 7 | Aaron Baar Mobile Marketer CTO. Social media and open source analyst. Seattle, Washington | Kargo adds 3 minority-owned publishers to amplifier program - 4 months ago | |
| 8 | James Brumley Motley Fool | Is Aramark Stock a Buy for 2024? - 5 months ago | |
| 9 | Robin Wigglesworth Financial Times | A quant winter’s tale - 5 months ago | |
| 10 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York |